Mankind Pharma Limited

NSE:MANKIND.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

🏬 Consumer Packaged Goods

💊 Drugstores & Retail Pharmacies

Location

India

Market Cap

USD 11.27 B

Share Price

USD 27.30

Avg Daily Volume

450,030

Change (1 day)

1.56%

Change (1 year)

6.75%

Change (YTD)

-18.88%

Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2025: USD -1.49 B

Mankind Pharma Limited Net Cash Used For Investing Activities is USD -1.49 B for the year ending March 31, 2025, a 495.12% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2024 was USD -249.57 M, a 92.26% change year over year.
Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -129.81 M, a -28.01% change year over year.
Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -180.32 M, a 8.03% change year over year.
Mankind Pharma Limited Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -166.92 M, a 186.43% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Depreciation And Amortization	Dividends Paid

NSE: MANKIND.NS

Mankind Pharma Limited

CEO	Mr. Sheetal Arora
IPO Date	May 9, 2023
Location	India
Headquarters	262, Okhla Industrial Estate
Employees	19,540
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 🏬 Consumer Packaged Goods 💊 Drugstores & Retail Pharmacies

Description

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.